These findings led to Phase I and II clinical trials of T4 eyedrops (RGN-259) for dry eye and neurotrophic keratopathy, making the ocular surface one of the most clinically advanced use areas for the broader T4/TB-500 compound class
BPC-157 remains one of the most well-researched and mechanistically coherent peptides available today
You can relax, read, listen to music, or even take a nap
Week-by-Week Results Timeline (2026) You need to enable JavaScript to run this app.
Manufactured in a facility that stores and/or processes Milk, Eggs, Fish, Crustacean shellfish, Tree nuts, Peanuts, Wheat and Soybeans
These services enable brands to create proprietary formulations combining N Acetyl L Carnosine Powder with complementary ingredients like hyaluronic acid for enhanced ocular surface hydration, antioxidant vitamins for synergistic free radical scavenging, or botanical extracts targeting specific therapeutic pathways